BCP Partnering Portal / BIOTON S.A.
BIOTON aims to reinforce its position of a biotechnological company with a global reach.
The Company is able to pursue its strategic objectives of protecting Patients’ health and improving the quality of their lives by participating in research and development projects, promoting the expansion of its product portfolio and making well-informed business decisions.
BIOTON fulfils its stated mission by implementing strategies and development plans aimed at:
reinforcing BIOTON's status on the Polish insulin market
promoting BIOTON's insulin world-wide by maximising its share of the existing markets and entering new ones
developing innovative, clinically important medicinal products, including biotechnological drugs developed by members of the BIOTON Group
expanding BIOTON’s generic drug portfolio.
recombinant human insulin in pharmaceutical substance form and as preparations for injections;
oral hypoglycemic drug - glimepiride
oral hypoglycemic drug – metformin
„BIOTON FOR HEALTH” is a new OTC products line of the BIOTON company.
The products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems (metabolic syndrome, diabetes) helping them to keep their organisms in optimal condition.
The products from „BIOTON FOR HEALTH” line contain natural ingredients of the highest quality, carefully balanced in composition.
Where Manufacturers and Channel Partners / Distributors find each other!